Skip to main content
Caplight Logo









TriNetX

TriNetX

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://trinetx.com/

Last Round

Corporate Funding

Apr 2, 2026

Total Funding Raised

$268.5M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

TriNetX is a healthcare technology company that operates a global health research network to enhance clinical trial design and recruitment through the integration of EMR data and clinical documentation.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Healthcare Analytics, Vertical SaaS, Biotechnology

Business Model

B2B

Customer Profile

Subscription SaaS, Data as a Service, Services & Consulting

AI Layer

Application

Keywords

clinical trial softwarereal-world evidenceRWEpatient recruitmentclinical trial techclinical data platformprotocol feasibilityclinical trial recruitmenthealth research networksite selectionclinical trial marketplaceclinical trial innovationhealth data exchangeDaaSdata as a serviceclinical trial AIclinical trial analyticstrial design

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TriNetX Comparables

Compare TriNetX with similar companies based on industry and business-model similarity.

TriNetX comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
nference
86%
OM1
84%
Truveta
82%

TriNetX Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingApr 2, 2026
Private EquitySep 21, 2020
Series DMar 13, 2019
Series AJun 1, 2015
Series BJun 1, 2015

TriNetX Investors

Notable investors and investment history

TriNetX investors
InvestorRounds
Deerfield ManagementSeries B, Series D
MPM CapitalSeries B, Series D, Series A
ITOCHU Technology VenturesSeries D
The Carlyle GroupPrivate Equity
ITOCHU Technology VenturesSeries D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 20, 2026

    Monthly visitors grew 55% MoM.

  • Apr 7, 2026

    Acquired key assets from current partner Zetta Genomics.

Recent news

Latest coverage and updates

  • promotesJul 27, 2026

    TriNetX, LLC was planning to promote Jeff Margolis to Chairman on Jul 27th '26.

  • hiresJul 27, 2026

    TriNetX, LLC hired August Calhoun as Chief Executive Officer on Jul 27th '26.

  • hiresJul 27, 2026

    TriNetX, LLC was planning to hire August Calhoun as Chief Executive Officer on Jul 27th '26.

  • recognized_asJul 15, 2026

    TriNetX, Inc. recognized as Platinum winner in AI Solutions for Clinical Research & Data Insights at 2026 Pinnacle Technology Awards on Jul 15th '26.

  • attends_eventJul 15, 2026

    TriNetX, Inc. attended event 2026 Pinnacle Technology Awards on Jul 15th '26.

TriNetX Filings

Explore SEC and related filing metadata, where available.

TriNetX filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about TriNetX's valuation, stock price, and market status.

Is TriNetX a public or private company?

TriNetX is a private company.

What is the current stock price of TriNetX?

TriNetX is a private company with no public stock price. No recent secondary market data is available.

How much is TriNetX worth (valuation)?

Valuation information for TriNetX is not publicly available.

Can I buy TriNetX stock?

TriNetX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was TriNetX's last funding round?

TriNetX's most recent funding round was Buyout/LBO on September 21, 2020.

Who are the main investors in TriNetX?

Key investors in TriNetX include MPM Capital.

Will TriNetX IPO soon?

No public IPO plans have been announced for TriNetX.

How can I track TriNetX secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor TriNetX's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range213
Year Founded2013
Last FundingApr 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?